跳至主要内容
临床试验/NCT02023346
NCT02023346已完成不适用

Prognostic Awareness and Patient-Physician Communication in Malignant Glioma

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2013年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
95
试验地点
1
主要终点
measure prognostic awareness

研究概览

简要总结

The purpose of this study is to learn more about the understanding patients with brain tumors have of their disease and their communication with their physician. Ultimately, we hope to use these findings to improve communication between patients and their doctors.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient Inclusion Criteria
  • Age greater than or equal to 18
  • Diagnosis of any WHO grade III or IV glioma
  • Admitted to the inpatient Neurology service
  • Has had at least one outpatient visit with a neuro-oncologist at MSKCC Fluent in English
  • Caregiver Inclusion Criteria
  • Age greater than or equal to 18
  • Identified by the patient as a relative, friend, or partner with whom he or she has a significant relationship and who provides him or her physical or emotional assistance.
  • The patient has himself or herself agreed to participate in this study

排除标准

  • Patient Exclusion Criteria
  • A patient will be excluded if the Glasgow Coma Scale is less than
  • The patient must be oriented to self, age, place, and year, and month.
  • Aphasia precluding comprehension and verbalization of consent to participate
  • Patients who cannot verbally demonstrate their understanding of the risks, benefits, and alternatives to participating in the study. This evaluation will take place for otherwise eligible and willing participants, and it will be performed by the NP or MD clinician who is obtaining informed consent and will be documented in the medical record.
  • Caregiver Exclusion Criteria
  • No eligible caregivers who can complete the brief assessment in person or via telephone will be excluded

结局指标

主要结局

measure prognostic awareness

时间窗: 2 years

Prognostic awareness (PA) will be measured using the Chochinov Prognostic Awareness Scale. This scale classifies patients into three categories of awareness: full, limited, or no awareness.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Prognostic Awareness and Patient-Physician... | 临床试验